Cash flow Unilever PLC

Equities

ULVR

GB00B10RZP78

Personal Products

Market Closed - London S.E. Other stock markets 16:35:09 05/12/2025 GMT			5-day change	1st Jan Change
4,456.00 ^GBX	+0.63%		-1.94%	-2.02%

12-05	UNILEVER PLC : Jefferies gives a Sell rating	ZD
12-05	Magnum Ice Cream's reference price for market debut set at 12.80 euros, Euronext says	RE

c3bd298fac2c0.TF_UI41bwl6VanQvcxhzBZrdV708uX2t6E1HfMAhN88.dS7jU7wBhWfxHkxBGWAfbcW_IOdj_wrUgSUhDLBJYKs-GudCyy30Ju8rIQ

Published financial data: UNILEVER PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	50.72B	52.44B	60.07B	59.6B	60.76B
Total Revenues	50.72B	52.44B	60.07B	59.6B	60.76B
Cost of Goods Sold, Total	28.68B	30.26B	35.91B	34.43B	33.39B
Gross Profit	22.04B	22.18B	24.17B	25.18B	27.37B
Selling General & Admin Expenses, Total	11.88B	11.71B	13.53B	15.13B	16.12B
R&D Expenses	800M	847M	908M	-	-
Other Operating Expenses	-	-11M	2M	-27M	3M
Other Operating Expenses, Total	12.68B	12.55B	14.44B	15.11B	16.12B
Operating Income	9.36B	9.64B	9.72B	10.07B	11.25B
Interest Expense, Total	-682M	-489M	-769M	-1.08B	-1.12B
Interest And Investment Income	235M	238M	305M	442M	451M
Net Interest Expenses	-447M	-251M	-464M	-633M	-667M
Income (Loss) On Equity Invest.	175M	191M	208M	231M	255M
Currency Exchange Gains (Loss)	-25M	7M	-29M	37M	5M
Other Non Operating Income (Expenses)	-21M	-9M	-20M	-	-
EBT, Excl. Unusual Items	9.04B	9.58B	9.42B	9.7B	10.84B
Restructuring Charges	-916M	-632M	-777M	-499M	-850M
Merger & Related Restructuring Charges	-69M	-136M	-8M	-242M	-387M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-22M	-
Gain (Loss) On Sale Of Assets	8M	-160M	2.29B	489M	-406M
Asset Writedown	-	-17M	-263M	-1M	-133M
Legal Settlements	-87M	-	-82M	107M	-
Other Unusual Items	20M	-74M	-246M	-196M	-195M
EBT, Incl. Unusual Items	8B	8.56B	10.34B	9.34B	8.87B
Income Tax Expense	1.92B	1.94B	2.07B	2.2B	2.5B
Earnings From Continuing Operations	6.07B	6.62B	8.27B	7.14B	6.37B
Net Income to Company	6.07B	6.62B	8.27B	7.14B	6.37B
Minority Interest	-492M	-572M	-627M	-653M	-625M
Net Income - (IS)	5.58B	6.05B	7.64B	6.49B	5.74B
Net Income to Common Incl Extra Items	5.58B	6.05B	7.64B	6.49B	5.74B
Net Income to Common Excl. Extra Items	5.58B	6.05B	7.64B	6.49B	5.74B
Per Share Items
Net EPS - Basic	2.13	2.33	3	2.58	2.3
Basic EPS - Continuing Operations	2.13	2.33	3	2.58	2.3
Basic Weighted Average Shares Outstanding	2.62B	2.6B	2.55B	2.52B	2.49B
Net EPS - Diluted	2.12	2.32	2.99	2.56	2.29
Diluted EPS - Continuing Operations	2.12	2.32	2.99	2.56	2.29
Diluted Weighted Average Shares Outstanding	2.63B	2.61B	2.56B	2.53B	2.51B
Normalized Basic EPS	1.97	2.08	2.06	2.15	2.47
Normalized Diluted EPS	1.96	2.07	2.06	2.14	2.45
Dividend Per Share	1.65	1.74	1.66	1.71	1.79
Payout Ratio	76.67	74.11	56.65	67.26	75.19
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	10.64B	10.73B	11.02B	11.06B	12.28B
EBITA	9.41B	9.69B	9.96B	10.11B	11.28B
EBIT	9.36B	9.64B	9.72B	10.07B	11.25B
EBITDAR	10.79B	10.88B	11.18B	11.23B	12.45B
Effective Tax Rate - (Ratio)	24.05	22.62	20.01	23.55	28.19
Total Current Taxes	2.28B	2.15B	2.27B	2.25B	2.65B
Total Deferred Taxes	-359M	-219M	-199M	-53M	-153M
Normalized Net Income	5.16B	5.41B	5.26B	5.41B	6.15B
Interest on Long-Term Debt	82M	72M	72M	72M	77M
Non-Cash Pension Expense	2M	-7M	-46M	-112M	-140M
Supplemental Operating Expense Items
Marketing Expenses	7.09B	6.87B	7.82B	8.55B	9.41B
Selling and Marketing Expenses	7.09B	6.87B	7.82B	8.55B	9.41B
Research And Development Expense From Footnotes	800M	847M	908M	949M	987M
Net Rental Expense, Total	154M	151M	167M	170M	168M
Imputed Operating Lease Interest Expense	30.24M	20.57M	34.46M	49.47M	48.73M
Imputed Operating Lease Depreciation	124M	130M	133M	121M	119M
Stock-Based Comp., Other (Total)	108M	161M	177M	212M	324M
Total Stock-Based Compensation	108M	161M	177M	212M	324M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.55B	3.42B	4.33B	4.16B	6.14B
Short Term Investments	691M	751M	772M	1.11B	736M
Trading Asset Securities, Total	277M	340M	500M	582M	446M
Total Cash And Short Term Investments	6.52B	4.51B	5.6B	5.85B	7.32B
Accounts Receivable, Total	3.43B	3.58B	4.54B	4.02B	4.23B
Other Receivables	933M	922M	1.13B	1.01B	955M
Notes Receivable	-	-	-	-	-
Total Receivables	4.37B	4.5B	5.68B	5.03B	5.18B
Inventory	4.46B	4.68B	5.93B	5.12B	5.18B
Prepaid Expenses	423M	492M	969M	516M	506M
Other Current Assets, Total	390M	3.22B	981M	1.38B	1.01B
Total Current Assets	16.16B	17.4B	19.16B	17.9B	19.19B
Gross Property Plant And Equipment	21.92B	22.06B	23.12B	22.84B	24.2B
Accumulated Depreciation	-11.36B	-11.71B	-12.35B	-12.13B	-12.53B
Net Property Plant And Equipment	10.56B	10.35B	10.77B	10.71B	11.67B
Long-term Investments	794M	1.06B	1B	1.22B	1.44B
Goodwill	18.94B	20.33B	21.61B	21.11B	22.31B
Other Intangibles, Total	16B	18.26B	18.88B	18.36B	18.59B
Accounts Receivable Long-Term	465M	499M	520M	394M	344M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.47B	1.46B	1.05B	1.11B	1.28B
Other Long-Term Assets, Total	3.27B	5.73B	4.84B	4.46B	4.92B
Total Assets	67.66B	75.1B	77.82B	75.27B	79.75B
Liabilities
Accounts Payable, Total	8.38B	8.9B	11.1B	10.36B	10.26B
Accrued Expenses, Total	4.67B	4.88B	5.86B	5.57B	5.61B
Short-term Borrowings	1.92B	4.03B	2.16B	1.58B	2.34B
Current Portion of Long-Term Debt	2.16B	2.85B	3.28B	3.17B	4.33B
Current Portion of Leases	380M	365M	340M	334M	322M
Current Income Taxes Payable	1.45B	1.36B	877M	851M	678M
Other Current Liabilities	1.64B	2.39B	1.82B	1.64B	1.7B
Total Current Liabilities	20.59B	24.78B	25.43B	23.51B	25.23B
Long-Term Debt	21.45B	21.6B	22.64B	23.47B	23.9B
Long-Term Leases	1.39B	1.28B	1.07B	1.06B	1.16B
Pension & Other Post Retirement Benefits	2.44B	2.13B	1.69B	1.38B	1.19B
Deferred Tax Liability Non Current	3.17B	4.53B	4.38B	4B	4.34B
Other Non Current Liabilities	967M	1.03B	914M	1.08B	1.36B
Total Liabilities	50B	55.35B	56.12B	54.5B	57.2B
Common Stock, Total	92M	92M	92M	88M	88M
Additional Paid In Capital	73.47B	52.84B	52.84B	52.84B	52.84B
Retained Earnings	22.55B	46.74B	50.25B	47.05B	49.72B
Treasury Stock	-483M	-3.41B	-4.81B	-6.24B	-2.3B
Comprehensive Income and Other	-80.36B	-79.17B	-79.36B	-75.64B	-80.37B
Total Common Equity	15.27B	17.11B	19.02B	18.1B	19.99B
Minority Interest	2.39B	2.64B	2.68B	2.66B	2.56B
Total Equity	17.66B	19.75B	21.7B	20.76B	22.56B
Total Liabilities And Equity	67.66B	75.1B	77.82B	75.27B	79.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.62B	2.56B	2.53B	2.5B	2.48B
ECS Total Common Shares Outstanding	2.62B	2.56B	2.53B	2.5B	2.48B
Book Value / Share	5.82	6.68	7.52	7.24	8.07
Tangible Book Value	-19.68B	-21.48B	-21.47B	-21.36B	-20.91B
Tangible Book Value Per Share	-7.5	-8.39	-8.49	-8.55	-8.45
Total Debt	27.3B	30.13B	29.49B	29.62B	32.05B
Net Debt	20.79B	25.63B	23.89B	23.77B	24.74B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-725M	-3.42B	-2.93B	-2.74B	-3.31B
Debt Equivalent Oper. Leases	1.23B	1.21B	1.34B	1.36B	1.34B
Minority Interest, Total (Incl. Fin. Div)	2.39B	2.64B	2.68B	2.66B	2.56B
Equity Method Investments, Total	63M	60M	84M	94M	94M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.52B	1.6B	2.06B	1.82B	1.91B
Inventories - Finished Goods, Total	3.22B	3.39B	4.25B	3.66B	3.57B
Land - (BS)	347M	380M	504M	471M	556M
Buildings, Total	3.86B	3.89B	4.1B	4.01B	4.31B
Machinery, Total	14.3B	14.46B	14.15B	13.9B	14.43B
Full Time Employees	149K	148K	127K	128K	116K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	193M	201M	188M	198M	179M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	5.58B	6.05B	7.64B	6.49B	5.74B
Depreciation & Amortization - CF	1.68B	1.47B	1.49B	1.35B	1.38B
Amortization of Goodwill and Intangible Assets - (CF)	54M	52M	239M	41M	35M
Depreciation & Amortization, Total	1.74B	1.52B	1.73B	1.39B	1.41B
Amortization of Deferred Charges, Total - (CF)	279M	222M	216M	187M	213M
(Gain) Loss From Sale Of Asset	60M	23M	-2.34B	-433M	436M
Asset Writedown & Restructuring Costs	-	17M	-	1M	133M
(Income) Loss On Equity Investments - (CF)	-178M	-282M	-232M	-209M	-268M
Stock-Based Compensation (CF)	108M	161M	177M	212M	324M
Other Operating Activities, Total	789M	305M	506M	976M	1.69B
Change In Accounts Receivable	1.12B	-307M	-1.85B	768M	-206M
Change In Inventories	-587M	-458M	-1.4B	340M	-198M
Change In Accounts Payable	142M	718M	2.83B	-294M	244M
Cash from Operations	9.06B	7.97B	7.28B	9.43B	9.52B
Capital Expenditure	-863M	-1.11B	-1.46B	-1.5B	-1.74B
Sale of Property, Plant, and Equipment	89M	101M	82M	42M	37M
Cash Acquisitions	-1.43B	-2.13B	-979M	-704M	-795M
Divestitures	39M	43M	4.62B	436M	985M
Sale (Purchase) of Intangible assets	-158M	-232M	-253M	-243M	-233M
Investment in Marketable and Equity Securities, Total	481M	-252M	-35M	-829M	426M
Other Investing Activities, Total	357M	333M	472M	506M	693M
Cash from Investing	-1.48B	-3.25B	2.45B	-2.29B	-625M
Short Term Debt Issued, Total	722M	656M	-	-	643M
Long-Term Debt Issued, Total	3.12B	4.75B	7.78B	4.97B	4.74B
Total Debt Issued	3.84B	5.4B	7.78B	4.97B	5.38B
Short Term Debt Repaid, Total	-	-	-545M	-570M	-
Long-Term Debt Repaid, Total	-4.02B	-4.01B	-8.96B	-4.3B	-4.69B
Total Debt Repaid	-4.02B	-4.01B	-9.5B	-4.87B	-4.69B
Repurchase of Common Stock	-	-3.02B	-1.51B	-1.51B	-1.51B
Common Dividends Paid	-4.28B	-4.48B	-4.33B	-4.36B	-4.32B
Common & Preferred Stock Dividends Paid	-4.28B	-4.48B	-4.33B	-4.36B	-4.32B
Other Financing Activities, Total	-1.34B	-988M	-1.32B	-1.43B	-1.81B
Cash from Financing	-5.8B	-7.1B	-8.89B	-7.19B	-6.94B
Foreign Exchange Rate Adjustments	-414M	285M	-7M	-119M	-48M
Net Change in Cash	1.36B	-2.09B	838M	-180M	1.9B
Supplemental Items
Cash Interest Paid	624M	488M	744M	899M	1.08B
Cash Income Tax Paid (Refund)	1.88B	2.33B	2.81B	2.14B	2.62B
Levered Free Cash Flow	7.88B	4.64B	7.47B	5.94B	6.31B
Unlevered Free Cash Flow	8.31B	4.95B	7.95B	6.62B	7.01B
Change In Net Working Capital	-1.35B	1.64B	-1.46B	-278M	0
Net Debt Issued / Repaid	-181M	1.39B	-1.73B	103M	697M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.83	8.44	7.95	8.22	9.07
Return on Total Capital	13.43	12.7	12.03	12.39	13.39
Return On Equity %	38.51	35.41	39.9	33.63	29.41
Return on Common Equity	39.22	37.37	42.31	34.95	30.16
Margin Analysis
Gross Profit Margin %	43.45	42.3	40.23	42.24	45.05
SG&A Margin	23.42	22.33	22.53	25.39	26.53
EBITDA Margin %	20.98	20.46	18.34	18.55	20.21
EBITA Margin %	18.56	18.47	16.59	16.96	18.57
EBIT Margin %	18.45	18.38	16.19	16.89	18.51
Income From Continuing Operations Margin %	11.97	12.62	13.76	11.98	10.48
Net Income Margin %	11	11.53	12.72	10.88	9.45
Net Avail. For Common Margin %	11	11.53	12.72	10.88	9.45
Normalized Net Income Margin	10.17	10.32	8.76	9.08	10.12
Levered Free Cash Flow Margin	15.54	8.85	12.44	9.97	10.38
Unlevered Free Cash Flow Margin	16.38	9.43	13.24	11.1	11.53
Asset Turnover
Asset Turnover	0.77	0.73	0.79	0.78	0.78
Fixed Assets Turnover	4.48	5.02	5.69	5.55	5.43
Receivables Turnover (Average Receivables)	12.15	14.95	14.79	13.91	14.73
Inventory Turnover (Average Inventory)	6.65	6.62	6.77	6.23	6.49
Short Term Liquidity
Current Ratio	0.78	0.7	0.75	0.76	0.76
Quick Ratio	0.53	0.36	0.44	0.46	0.5
Operating Cash Flow to Current Liabilities	0.44	0.32	0.29	0.4	0.38
Days Sales Outstanding (Average Receivables)	30.12	24.41	24.69	26.23	24.85
Days Outstanding Inventory (Average Inventory)	55.03	55.16	53.95	58.57	56.43
Average Days Payable Outstanding	110.91	103.41	98.22	116.47	112.77
Cash Conversion Cycle (Average Days)	-25.76	-23.84	-19.59	-31.67	-31.5
Long Term Solvency
Total Debt/Equity	154.66	152.6	135.88	142.66	142.11
Total Debt / Total Capital	60.73	60.41	57.61	58.79	58.7
LT Debt/Equity	129.39	115.88	109.27	118.16	111.13
Long-Term Debt / Total Capital	50.81	45.87	46.32	48.69	45.9
Total Liabilities / Total Assets	73.91	73.71	72.11	72.41	71.72
EBIT / Interest Expense	13.72	19.71	12.65	9.37	10.06
EBITDA / Interest Expense	16.27	22.82	14.9	10.66	11.32
(EBITDA - Capex) / Interest Expense	15.01	20.56	13	9.26	9.77
Total Debt / EBITDA	2.46	2.7	2.57	2.59	2.53
Net Debt / EBITDA	1.87	2.3	2.09	2.07	1.95
Total Debt / (EBITDA - Capex)	2.67	3	2.95	2.97	2.94
Net Debt / (EBITDA - Capex)	2.03	2.55	2.39	2.39	2.27
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.42	3.39	14.55	-0.78	1.94
Gross Profit, 1 Yr. Growth %	-3.66	0.66	8.93	4.17	8.72
EBITDA, 1 Yr. Growth %	-4.39	0.86	2.48	3.3	10.54
EBITA, 1 Yr. Growth %	-5.63	2.94	2.84	2.37	11.03
EBIT, 1 Yr. Growth %	-5.64	2.98	0.91	4.48	11.14
Earnings From Cont. Operations, 1 Yr. Growth %	0.78	9.02	24.89	-13.65	-10.8
Net Income, 1 Yr. Growth %	-0.78	8.39	26.33	-15.11	-11.45
Normalized Net Income, 1 Yr. Growth %	-6.79	4.93	-2.81	3.97	12.97
Diluted EPS Before Extra, 1 Yr. Growth %	-0.93	9.43	28.88	-14.38	-10.55
Accounts Receivable, 1 Yr. Growth %	-30.17	4.34	26.86	-11.47	5.07
Inventory, 1 Yr. Growth %	7.16	4.95	26.65	-13.69	1.13
Net Property, Plant and Equip., 1 Yr. Growth %	-12.47	-2	4.09	-0.58	8.98
Total Assets, 1 Yr. Growth %	4.4	10.99	3.63	-3.28	5.96
Tangible Book Value, 1 Yr. Growth %	10.3	9.19	-0.07	-0.48	-2.12
Common Equity, 1 Yr. Growth %	15.72	12.06	11.19	-4.83	10.43
Cash From Operations, 1 Yr. Growth %	11.7	-11.99	-8.66	29.44	0.99
Capital Expenditures, 1 Yr. Growth %	-34.42	28.39	31.41	3.16	15.71
Levered Free Cash Flow, 1 Yr. Growth %	28.89	-39.48	60.5	-17.27	5.55
Unlevered Free Cash Flow, 1 Yr. Growth %	26.11	-38.89	60.3	-13.83	5.39
Dividend Per Share, 1 Yr. Growth %	-2	5.25	-4.29	2.52	4.99
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.25	0.45	8.83	6.61	0.57
Gross Profit, 2 Yr. CAGR %	-0.54	-1.53	4.71	6.53	6.42
EBITDA, 2 Yr. CAGR %	-3.12	-4.96	-1.6	-1.44	4.54
EBITA, 2 Yr. CAGR %	0.44	-1.16	3.19	2.42	8.91
EBIT, 2 Yr. CAGR %	0.16	-1.42	1.94	2.21	8.74
Earnings From Cont. Operations, 2 Yr. CAGR %	-21.23	4.82	16.69	3.85	-12.24
Net Income, 2 Yr. CAGR %	-22.82	3.7	17.02	3.56	-13.3
Normalized Net Income, 2 Yr. CAGR %	-0.18	-1.1	0.99	-0.01	9.52
Diluted EPS Before Extra, 2 Yr. CAGR %	-21.95	4.12	18.76	5.05	-12.49
Accounts Receivable, 2 Yr. CAGR %	-11.16	-14.64	15.05	5.98	-3.55
Inventory, 2 Yr. CAGR %	1.85	6.05	15.29	4.55	-6.57
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.54	-7.38	1	1.72	4.09
Total Assets, 2 Yr. CAGR %	5.22	7.65	7.25	0.11	1.23
Tangible Book Value, 2 Yr. CAGR %	4.27	9.75	4.46	-0.28	-1.31
Common Equity, 2 Yr. CAGR %	15.74	13.88	11.62	2.87	2.52
Cash From Operations, 2 Yr. CAGR %	11.26	-0.85	-10.34	8.74	14.33
Capital Expenditures, 2 Yr. CAGR %	-19.42	-8.24	29.89	16.43	9.26
Levered Free Cash Flow, 2 Yr. CAGR %	-6.77	-12.86	-1.18	13.25	-5.79
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.61	-13.36	-0.86	15.66	-3.98
Dividend Per Share, 2 Yr. CAGR %	4.91	1.5	0.36	-0.8	3.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.89	0.95	4.94	5.52	5.03
Gross Profit, 3 Yr. CAGR %	-1.74	-0.14	1.84	4.53	7.25
EBITDA, 3 Yr. CAGR %	-0.93	-1.81	-2.49	-0.94	2.56
EBITA, 3 Yr. CAGR %	0.03	1.27	0.16	2.61	5.39
EBIT, 3 Yr. CAGR %	-0.16	1.09	-0.65	2.47	5.28
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.02	-12.22	11.12	5.54	-1.29
Net Income, 3 Yr. CAGR %	-2.51	-13.57	10.75	5.14	-1.71
Normalized Net Income, 3 Yr. CAGR %	-0.42	1.5	-1.68	1.61	4.35
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.31	-12.64	11.79	6.49	-0.43
Accounts Receivable, 3 Yr. CAGR %	-13.03	-6.27	-2.59	5.43	5.67
Inventory, 3 Yr. CAGR %	4.04	2.88	12.51	4.69	3.4
Net Property, Plant and Equip., 3 Yr. CAGR %	-4.89	-5.05	-3.71	0.47	4.09
Total Assets, 3 Yr. CAGR %	2.92	7.11	6.29	3.62	2.02
Tangible Book Value, 3 Yr. CAGR %	9.56	5.89	6.37	2.78	-0.9
Common Equity, 3 Yr. CAGR %	4.34	14.5	12.97	5.84	5.33
Cash From Operations, 3 Yr. CAGR %	4.76	2.89	-3.52	1.34	6.09
Capital Expenditures, 3 Yr. CAGR %	-16.99	-5.88	3.43	20.29	16.19
Levered Free Cash Flow, 3 Yr. CAGR %	37.21	-20.02	6.94	-8.08	10.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	33.57	-19.62	6.49	-6.5	12.32
Dividend Per Share, 3 Yr. CAGR %	4.97	4.98	-0.48	1.17	0.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.98	-0.1	2.26	3.17	3.17
Gross Profit, 5 Yr. CAGR %	-0.38	-0.27	0.79	2.47	3.65
EBITDA, 5 Yr. CAGR %	3.96	3.19	0.13	-0.5	0.66
EBITA, 5 Yr. CAGR %	4.19	3.86	1.16	1.62	2.61
EBIT, 5 Yr. CAGR %	4.82	4.57	0.67	1.54	2.55
Earnings From Cont. Operations, 5 Yr. CAGR %	2.92	3.6	5.07	-6.11	1.11
Net Income, 5 Yr. CAGR %	2.6	3.13	4.88	-7.09	0.42
Normalized Net Income, 5 Yr. CAGR %	4.38	4.68	0.14	0.89	2.13
Diluted EPS Before Extra, 5 Yr. CAGR %	4.27	4.97	6.92	-5.96	1.36
Accounts Receivable, 5 Yr. CAGR %	3.31	1.48	-2.73	-1.55	-2.97
Inventory, 5 Yr. CAGR %	0.58	1.83	8.4	3.54	4.45
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.92	-2.38	-2.57	-2.4	-0.66
Total Assets, 5 Yr. CAGR %	5.29	5.88	4.63	4.25	4.24
Tangible Book Value, 5 Yr. CAGR %	15.38	14.16	7.49	3.38	3.23
Common Equity, 5 Yr. CAGR %	-0.23	0.9	7.19	9.7	8.67
Cash From Operations, 5 Yr. CAGR %	4.32	2.5	-1.56	5.19	3.26
Capital Expenditures, 5 Yr. CAGR %	-14.3	-9.29	-0.71	2.48	5.72
Levered Free Cash Flow, 5 Yr. CAGR %	11.22	3.7	19.63	-8.1	0.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.79	3.19	17.94	-7.03	1.24
Dividend Per Share, 5 Yr. CAGR %	6.45	6.32	3.07	2.63	1.19